Rita Nanda to Maximum Tolerated Dose
This is a "connection" page, showing publications Rita Nanda has written about Maximum Tolerated Dose.
Connection Strength
0.073
-
First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer. Invest New Drugs. 2021 10; 39(5):1348-1356.
Score: 0.046
-
A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2013 May; 139(1):145-53.
Score: 0.027